BMRX Financing Plan announced in March 19 press release:
"Robert Hoyt, managing partner at Crestview Capital, the majority owner of Biometric Investors, LLC. "Crestview has agreed to take the lead in bioMETRX's next round of funding that is expected to total between $11.0 and $15.0 million, including the contribution of assets valued in excess of $5 million dollars," added Mr. Hoyt."
$11 to $15 Million in funding at normal 50% discount ($.20)from trailing 5 day bid price average would be from a low of 55,000,000 shares for $11,000,000 and 75,000,000 for $15,000,000.
Finally in Bankruptcy court Sequiam had less than $500,000 assets not the $5,000,000 BIL was claiming to transfer in the deal.
